Prostate-specific G-protein coupled receptor (PSGR) is a member of the G-protein coupled odorant receptor family, and is highly expressed in prostate cancer cells compared with normal prostate cells [23]–[25], suggesting that PSGR may be targeted for the development of novel immunotherapeutic strategies against prostate cancer. The gene discussed is OR51E2; the disease is prostate carcinoma.